Gene expression profiling as a prognostic tool in multiple myeloma. | Cancer Drug Resist;4(4): 1008-1018, 2021. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Gene expression profiling as a prognostic tool in multiple myeloma.

Black, Harmony; Glavey, Siobhan.

Affiliation

Black H; Department of Haematology, Beaumont Hospital, Dublin D09 V2N0, Ireland.
Glavey S; Department of Haematology, Beaumont Hospital, Dublin D09 V2N0, Ireland.

Cancer Drug Resist ; 4(4): 1008-1018, 2021.

Article in En | MEDLINE | ID: mdl-35582380

Key words

Multiple myeloma; SKY92; drug resistance; gene expression profiling; prognostication; risk stratification; risk-adapted therapies

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancer Drug Resist Year: 2021 Document type: Article Affiliation country: Ireland Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancer Drug Resist Year: 2021 Document type: Article Affiliation country: Ireland Country of publication: United States